Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
Open Access
- 1 December 2005
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 106 (12) , 3791-3796
- https://doi.org/10.1182/blood-2005-05-1938
Abstract
Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4) bound to heparin. Immunogenicity oKeywords
This publication has 48 references indexed in Scilit:
- Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopeniaBlood, 2005
- Role of Sulfated Polysaccharides in the Pathogenesis of Heparin- Induced ThrombocytopeniaPublished by Taylor & Francis ,2003
- Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevanceBlood, 2003
- The Pharmacokinetics of Fondaparinux Sodium in Healthy VolunteersClinical Pharmacokinetics, 2002
- The epitope specificity of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Generalizations of current status data with applicationsLifetime Data Analysis, 1995
- Pentosan‐induced thrombocytopenia: support for an immune complex mechanismBritish Journal of Haematology, 1994